Search Results
Dec 02, 2025, 09:05 ET RÉMY MARTIN UNVEILS LUNAR NEW YEAR COLLABORATION CELEBRATING THE YEAR OF THE HORSE
collages fusing remnants of classical Chinese artworks with Western pop culture references, playing with the tension between high and low, East and West, mass and singular, traditional craft and throwaway culture. "Every year, I cut from maybe a thousand books and piles of old newspapers and photographs searching
More news about: Rémy Martin
Dec 02, 2025, 09:00 ET Cellid Announces Two New Reference Designs for Next-Generation AR Glasses
model.Of these two models, the monochrome green model features the latest plastic waveguide (display lens for AR glasses), which Cellid has successfully mass-produced for the first time globally, while the full-color model features a glass waveguide. Both models are wireless, offer excellent design, and are
More news about: Cellid, Inc.
Dec 02, 2025, 09:00 ET National Grid Launches AI-Powered Wildfire Risk Initiative with Rhizome
WALTHAM, Mass. and ALBANY, N.Y., Dec. 2, 2025 /PRNewswire/ -- As wildfire risk increases across the Northeast, National Grid is taking action to improve resilience for its customers and communities. Today, the company announced
More news about: National Grid
Dec 02, 2025, 09:00 ET Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
this community, which remains without approved therapies," said Hanny Al-Samkari, MD, The Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Mass General Brigham Cancer Institute, Associate Professor of Medicine at Harvard Medical School and the co-lead principal investigator in the study.Study
More news about: Vaderis Therapeutics AG
Dec 02, 2025, 09:00 ET Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
this community, which remains without approved therapies," said Hanny Al-Samkari, MD, The Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Mass General Brigham Cancer Institute, Associate Professor of Medicine at Harvard Medical School and the co-lead principal investigator in the study.Study
More news about: Vaderis Therapeutics AG
Dec 02, 2025, 09:00 ET TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen
extracorporeally-retained T cells using the FABfinity cell selection method at both clinical and commercial scale.CAMBRIDGE, Mass. and MARTINSRIED, Germany, Dec. 2, 2025 /PRNewswire/ -- Kytopen Corp., a leader in non-viral, continuous
More news about: Kytopen
Dec 02, 2025, 09:00 ET EF Ultimate Break Names Portugal Its 2026 "Destination of the Year," Celebrating Travel That Feels Real, Restorative, and Adventurous
& Experiences for College Students in 2026 shaping where young travelers want to go in 2026CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ --
More news about: EF Ultimate Break
Dec 02, 2025, 09:00 ET Nature Communications | Insilico Medicine Presents AI-empowered Dual-Action PROTAC Targeting PKMYT1
bioavailability in preclinical studies and has now advanced to the pre-candidate validation stage.CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- PKMYT1 (Membrane-associated Tyrosine/Threonine Protein Kinase 1) is a serine/threonine
More news about: Insilico Medicine
Dec 02, 2025, 08:45 ET MetaVia Inc. Announces 1-for-11 Reverse Stock Split
CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA) ("MetaVia" or the "Company"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today
More news about: MetaVia Inc.
Dec 02, 2025, 08:15 ET Uncrustables® Donates 1 Million Sandwiches to Boys & Girls Clubs Across the Country
Holder LLC. The Dunkin'® brand is licensed to The J.M. Smucker Co. for packaged coffee products sold in retail channels, such as grocery stores, mass merchandisers, club stores, e-commerce and drug stores, as well as in certain away from home channels. This information does not pertain to products
More news about: The J.M. Smucker Co.
Dec 02, 2025, 08:00 ET Sigma Squared Named to Inc.'s Best in Business List for Best AI Implementation, Capping Breakout Year of Product Innovation
analytics suite and deepen its impact across law enforcement, hospitality, and enterprise sectors. CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ --
More news about: Sigma Squared
Dec 02, 2025, 08:00 ET Insilico Medicine and Atossa Therapeutics Publish AI-Driven Study in Nature Scientific Reports Identifying (Z)-Endoxifen as a Potential Therapeutic Candidate for Glioblastoma
CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- Insilico Medicine ("Insilico"), a global leader in AI-powered drug discovery, and Atossa Therapeutics ("Atossa") (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing
More news about: Atossa Therapeutics Inc
Dec 02, 2025, 08:00 ET DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
Chief Commercial Officer. "With outcomes such as a 1.4% reduction in eHbA1c, a 38% reduction in blood pressure by one stage and an average 10% Body Mass Index (BMI) reduction among participants, we are showing that our platform doesn't just engage – it delivers. These evidence-based results are resonating
More news about: DarioHealth Corp.
Dec 02, 2025, 08:00 ET Valens Semiconductor and Imavix Engineering Combine to Offer the First MIPI A-PHY-Based Platform for Machine Vision; CIS Corporation Announces the Industry's First A-PHY-Compliant Camera, Integrating the Valens VA7000 Chipset
CIS leverages multiple specialized development teams with deep expertise in camera and image processing system & software design, prototyping, and mass production. With over four decades of innovation and commitment to excellence, CIS continues to drive the evolution of imaging technology.Forward-Looking
More news about: Valens Semiconductor
Dec 02, 2025, 07:09 ET American Liver Foundation Hosts the 34th Annual Irwin M. Arias Symposium
HealthBile Acids as the Master Regulators of Immunity in the Liver Siva Karthik Varanasi, PhD, U Mass Chan Medical School Hemodynamics in Fontan Associated Liver DiseaseEllen Roche, PhD, Massachusetts
More news about: American Liver Foundation
Dec 02, 2025, 07:08 ET Octillion Achieves Solar-Powered Manufacturing at EV Battery System Facility in India
delivered energy in 2024. Octillion is a turnkey battery supplier for the transportation market providing its customers with a bridge from design to mass-scale manufacturing. Octillion products undergo a robust design process, including extensive thermal modeling, fully integrated battery management systems,
More news about: Octillion Power Systems
Dec 02, 2025, 07:08 ET Octillion Achieves Solar-Powered Manufacturing at EV Battery System Facility in India
delivered energy in 2024. Octillion is a turnkey battery supplier for the transportation market providing its customers with a bridge from design to mass-scale manufacturing. Octillion products undergo a robust design process, including extensive thermal modeling, fully integrated battery management systems,
More news about: Octillion Power Systems
Dec 02, 2025, 06:42 ET Prefilled Syringes (PFS) Market Size to Grow USD 32.98 Billion by 2035 at a CAGR 13.75 | Vantage Market Research
routine injections, vaccines, anticoagulants, and specialty drugs. Their simplicity, low cost, and ease of filling make them the preferred choice for mass-market therapeutics.Dual-Chamber Prefilled Syringes: Dual-chamber formats are rising in demand for lyophilized biologics requiring reconstitution
More news about: Vantage Market Research
Dec 02, 2025, 06:00 ET Rubenstein Law Obtains $6 Million Jury Verdict for Widow of Worker Killed by a Metromover Train
injuries, premises liability, medical malpractice, child & birth injury, motorcycle accident cases, and traumatic brain injury cases. The firm's Mass Tort division represents clients nationwide in defective products, dangerous drugs, and chemical cases.
More news about: Rubenstein Law
Dec 02, 2025, 06:00 ET CHASM Drives Green Concrete Innovation, Strengthening Norman, Oklahoma's Advanced Materials Leadership
Pioneering Carbon Nanotube (CNT) Technology Achieves Stronger, More Sustainable Concrete at ScaleCANTON, Mass. and NORMAN, Okla., Dec. 2, 2025 /PRNewswire/ -- Chasm Advanced Materials, Inc. (CHASM), a U.S.-based leader
More news about: CHASM Advanced Materials
Dec 02, 2025, 05:00 ET Blood Test Shows Obesity Speeds Alzheimer's Development
spinal cord) using six leading commercial tests.The researchers performed statistical analysis to assess the association between the BBMs and body mass index (BMI) and the three-way interaction between baseline obesity, time and BBMs. The researchers also validated the BBMs against the amyloid PET scans.Analysis
More news about: Radiological Society of North America (RSNA)
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
biosimilars on the market by 2030."Addressing the burden of osteoporosisOsteoporosis is a chronic condition characterised by reduced bone mass and structural deterioration, leading to an increased risk of fractures.It affects more than 200 million people globally, with around one in
More news about: Accord Healthcare
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
biosimilars on the market by 2030."Addressing the burden of osteoporosisOsteoporosis is a chronic condition characterised by reduced bone mass and structural deterioration, leading to an increased risk of fractures.It affects more than 200 million people globally, with around one in
More news about: Accord Healthcare
Dec 01, 2025, 16:30 ET Cognex Announces Participation at Upcoming Investor Conferences
NATICK, Mass., Dec. 1, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today announced that its Chief Financial Officer, Dennis Fehr, will present at the following
More news about: Cognex Corporation
Dec 01, 2025, 16:05 ET Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWTON, Mass., Dec. 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted a stock option to
More news about: Karyopharm Therapeutics Inc.